Education Center

Test Selection and Interpretation Guide

Test Selection and Interpretation Guide 2012

This useful guide provides testing information in 9 clinical specialties: cardiology, chronic kidney disease, coagulation, endocrinology, genetics, hematology/oncology, immunology, infectious diseases, and toxicology. The information provided is based on peer-reviewed publications.

Upcoming Events

Visit Our New Upcoming Events Center For Event Details

Is your patient at increased risk for hereditary breast and ovarian cancer?

Compared to the general population, a woman with a confirmed BRCA1 or BRCA2 mutation is at greater risk of developing cancer during her lifetime—up to an 85% risk of breast cancer and up to a 40% risk of ovarian cancer. Her children, siblings and parents have a 50% chance of having the same autosomal dominant mutation and facing comparable risks. Learn more.

Putting Vitamin D to the Test: The QuestAssureD™ Difference

To learn more about the differences in vitamin D testing methodologies and why methodology matters, watch this brief two minute video.


Robert superko photo

Review of Clinical Research and the Effective Use of Omega -3 &-6 Fatty Acids in Patient Management

Robert Superko, MD, and Michael Caulfield, PhD, discuss the current clinical research on the use of Omega -3 and -6 supplementation and their link to decreased risk of cardiovascular events, including sudden cardiac death. They will also discuss the clinical management of patients including the use of the Omega -3 & -6, Fatty Acid laboratory test as a marker of cardiovascular risk.

Dr. waldman - 2014 headshot

BRCAvantage™: An In-depth Discussion

Quest Diagnostics’ Frederic Waldman, MD, and Wendy Conlon, CGC, will present an in-depth look at BRCA1 and BRCA2 testing, describe the role of the genetic counselor in the management of patients and explain the details of the Quest Diagnostics BRCAvantage™ tests and how to interpret results.

See More

Search Education Center

Advanced Search

Browse Presentations By:

Omega-3 and Omega-6 Fatty Acids – Measuring Blood Levels To Help Manage Cardiovascular Risk

While recommendations for dietary intake of omega-3 fatty acids to reduce cardiovascular disease risk are well established, debate continues about the benefits of...

Epilepsy: How Next-Generation Genetic Testing Can Direct Therapy and Enhance Patient Care

Many types of epilepsy are associated with a genetic mutation, but determining the etiology of certain epilepsies remains a challenge. Dr. Scott...

BRCA Mutation Testing – Identifying Risk for Hereditary Breast and Ovarian Cancer

Compared to the general population, patients with a confirmed BRCA mutation have a significantly increased risk of developing cancer during their lifetime -...

Developmental Delay: Genetic Testing’s Role to Help Guide Diagnosis and Treatment

Causes of developmental delay are typically identified by a combination of observation, physical examination, assessment of family history and a range of diagnostic...

Vitamin D Testing – Increasing Accuracy, Improving Patient Management

The National Institutes of Health are in the process of establishing a standardized approach for vitamin D Testing. This promises to improve the...

A New Algorithm for HIV Laboratory Testing

The Centers for Disease Control and Prevention (CDC) has proposed a new algorithm for laboratory testing of human immunodeficiency virus (HIV) to replace...

Test Selection and Interpretation Guide
Test Selection and Interpretation Guide

View Now

This useful guide provides testing information in 9 clinical specialties.

Directory of Services ebook
Directory of Services ebook

Focus Diagnostics
Chantilly/San Juan Capistrano

Select laboratory to view an ebook version of the Quest Diagnostics Nichols Institute test catalog

Test FAQs
Test FAQs

View Now

See answers to some of the most common questions about Quest Diagnostics laboratory tests.